Novel approaches to drug discovery for the treatment of type 2 diabetes

Bibliography

• Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab 2012;3:198
   Google Scholar
• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013;93:137-88
   PubMed Web of Science ®Google Scholar
• Guariguata L, Whiting D, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2013;103:137-49
   Google Scholar
• Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001;414:821-7
   PubMed Web of Science ®Google Scholar
• Wheeler E, Barroso I. Genome-wide association studies and type 2 diabetes. Brief Funct Genomics 2011;10:52-60
   PubMed Web of Science ®Google Scholar
• Grarup N, Sparso T, Hansen T. Physiologic characterization of type 2 diabetes-related loci. Curr Diab Rep 2010;10:485-97
   PubMed Web of Science ®Google Scholar
• Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet 2011;378:182-97
   PubMed Web of Science ®Google Scholar
• Lebovitz HE. Type 2 diabetes mellitus--current therapies and the emergence of surgical options. Nat Rev Endocrinol 2011;7:408-19
   PubMed Web of Science ®Google Scholar
• Verspohl EJ. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev 2012;64:188-237
   PubMed Web of Science ®Google Scholar
• Chao EC, Henry RR. SGLT2 inhibition--a novel strategy for diabetes treatment. Nat Rev Drug Discov 2010;9:551-9
   PubMed Web of Science ®Google Scholar
• Maedler K, Carr RD, Bosco D, et al. Sulfonylurea induced beta-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 2005;90:501-6
   PubMed Web of Science ®Google Scholar
• Del Guerra S, Marselli L, Lupi R, et al. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diab Complications 2005;19:60-4
   PubMed Web of Science ®Google Scholar
• Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ Health Perspect 2012;120:779-89
   PubMed Web of Science ®Google Scholar
• Inadera H. Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals. Environ Health Prev Med 2013;18:185-97
   PubMed Web of Science ®Google Scholar
• Nyirjesy P, Sobel JD. Genital mycotic infections in patients with diabetes. Postgrad Med 2013;125:33-46
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang C, Wu J, Zhang G. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. Diabetes Res Clin Pract 2013;99:200-8
   PubMed Web of Science ®Google Scholar
• Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14-24
   PubMed Web of Science ®Google Scholar
• Meier JJ. Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008;51:703-13
   PubMed Web of Science ®Google Scholar
• Kaneto H, Matsuoka T-A. Down-regulation of pancreatic transcription factors and incretin receptors in type 2 diabetes. World J Diabetes 2013;4:263
   Google Scholar
• Meier JJ, Bonadonna RC. Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 2013;36(Suppl 2):S113-19
   Google Scholar
• RP R. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004;350:694-705
   PubMed Web of Science ®Google Scholar
• Jun HS. Regeneration of pancreatic beta cells. Front Biosci 2008;13:6170-82
   PubMed Web of Science ®Google Scholar
• Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5’-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 2003;144:1444-55
   PubMed Web of Science ®Google Scholar
• Han SJ, Kang ES, Hur KY, et al. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis. Horm Res 2008;70:165-73
   PubMed Web of Science ®Google Scholar
• Chen YC, Fueger PT, Wang Z. Depletion of PAK1 enhances ubiquitin-mediated Survivin degradation in pancreatic beta-cells. Islets 2013;5:22-8
   PubMed Web of Science ®Google Scholar
• Furuya F, Shimura H, Yamashita S, et al. Liganded thyroid hormone receptor-alpha enhances proliferation of pancreatic beta-cells. J Biol Chem 2010;285:24477-86
   PubMed Web of Science ®Google Scholar
• Pfefferkorn JA. Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes. Expert Opin Drug Discov 2013;8:319-30
   PubMed Web of Science ®Google Scholar
• Porat S, Weinberg-Corem N, Tornovsky-Babaey S, et al. Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab 2011;13:440-9
   PubMed Web of Science ®Google Scholar
• Qi Y, Chen J, Lay A, et al. Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic beta-cell death in diet-induced obese mice. FASEB J 2013;27:4294-304
   PubMed Web of Science ®Google Scholar
• Caton PW, Richardson SJ, Kieswich J, et al. Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia 2013;56:1068-77
   PubMed Web of Science ®Google Scholar
• Vasavada RC, Wang L, Fujinaka Y, et al. Protein kinase C-zeta activation markedly enhances beta-cell proliferation: an essential role in growth factor mediated beta-cell mitogenesis. Diabetes 2007;56:2732-43
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu H, Gao L, et al. Elevated toll-like receptor 3 inhibits pancreatic beta-cell proliferation through G1 phase cell cycle arrest. Mol Cell Endocrinol 2013;377:112-22
   PubMed Web of Science ®Google Scholar
• Kitamura T. The role of FOXO1 in beta-cell failure and type 2 diabetes mellitus. Nat Rev Endocrinol 2013;9:615-23
   PubMed Web of Science ®Google Scholar
• Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011;91:827-87
   PubMed Web of Science ®Google Scholar
• Poy MN, Hausser J, Trajkovski M, et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci USA 2009;106:5813-18
   PubMed Web of Science ®Google Scholar
• Jacovetti C, Abderrahmani A, Parnaud G, et al. MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. J Clin Invest 2012;122:3541-51
   PubMed Web of Science ®Google Scholar
• Nesca V, Guay C, Jacovetti C, et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 2013;56:2203-12
   PubMed Web of Science ®Google Scholar
• Pullen TJ, Rutter GA. Could lncRNAs contribute to beta-cell identity and its loss in type 2 diabetes? Biochem Soc Trans 2013;41:797-801
   PubMed Web of Science ®Google Scholar
• MacDonald PE, Joseph JW, Rorsman P. Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 2005;360:2211-25
   PubMedGoogle Scholar
• Zhang Y, Xie Z, Zhou L, et al. The zinc finger protein ZBTB20 regulates transcription of fructose-1,6-bisphosphatase 1 and beta cell function in mice. Gastroenterology 2012;142:1571-80. e1576
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xie Z, Zhou G, et al. Fructose-1,6-bisphosphatase regulates glucose-stimulated insulin secretion of mouse pancreatic beta-cells. Endocrinology 2010;151:4688-95
   PubMed Web of Science ®Google Scholar
• Wiederkehr A, Wollheim CB. Mitochondrial signals drive insulin secretion in the pancreatic beta-cell. Mol Cell Endocrinol 2012;353:128-37
   PubMed Web of Science ®Google Scholar
• Wang C, Li X, Mu K, et al. Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function. Diabetologia 2013;56:1999-2009
   PubMed Web of Science ®Google Scholar
• Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 2005;85:1303-42
   PubMed Web of Science ®Google Scholar
• Mancini AD, Poitout V. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Trends Endocrinol Metab 2013;24:398-407
   PubMed Web of Science ®Google Scholar
• Amisten S, Salehi A, Rorsman P, et al. An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans. Pharmacol Ther 2013;139:359-91
   PubMed Web of Science ®Google Scholar
• Ha TY, Kim YS, Kim CH, et al. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus. Arch Pharm Res 2014;37:671-8
   PubMed Web of Science ®Google Scholar
• Dezaki K, Yada T. Islet beta-cell ghrelin signaling for inhibition of insulin secretion. Methods Enzymol 2012;514:317-31
   PubMed Web of Science ®Google Scholar
• Song WJ, Seshadri M, Ashraf U, et al. Snapin mediates incretin action and augments glucose-dependent insulin secretion. Cell Metab 2011;13:308-19
   PubMed Web of Science ®Google Scholar
• Ustione A, Piston DW. Dopamine synthesis and D3 receptor activation in pancreatic beta-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations. Mol Endocrinol 2012;26:1928-40
   PubMed Web of Science ®Google Scholar
• Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 2008;389:305-12
   PubMed Web of Science ®Google Scholar
• Lovis P, Roggli E, Laybutt DR, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008;57(10):2728-36
   PubMed Web of Science ®Google Scholar
• Sun LL, Jiang BG, Li WT, et al. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract 2011;91:94-100
   PubMed Web of Science ®Google Scholar
• Fred RG, Bang-Berthelsen CH, Mandrup-Poulsen T, et al. High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One 2010;5:e10843
   PubMedGoogle Scholar
• Marchi S, Giorgi C, Suski JM, et al. Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct 2012;2012:329635
   PubMedGoogle Scholar
• Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal 2010;12:537-77
   PubMed Web of Science ®Google Scholar
• Gems D, Partridge L. Stress-response hormesis and aging: "that which does not kill us makes us stronger". Cell Metab 2008;7:200-3
   PubMed Web of Science ®Google Scholar
• Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005;23:197-223
   PubMed Web of Science ®Google Scholar
• Crujeiras AB, Diaz-Lagares A, Carreira MC, et al. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res 2013;47:243-56
   PubMed Web of Science ®Google Scholar
• Kondo K, Ishigaki Y, Gao J, et al. Bach1 deficiency protects pancreatic beta-cells from oxidative stress injury. Am J Physiol Endocrinol Metab 2013;305:E641-8
   Google Scholar
• Latha R, Shanthi P, Sachdanandam P. Kalpaamruthaa modulates oxidative stress in cardiovascular complication associated with type 2 diabetes mellitus through PKC-beta/Akt signaling. Can J Physiol Pharmacol 2013;91:901-12
   PubMed Web of Science ®Google Scholar
• Kang KA, Kim KC, Bae SC, Hyun JW. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway. Int J Oncol 2013;43:1511-16
   PubMed Web of Science ®Google Scholar
• Zuo L, Motherwell MS. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson’s disease. Gene 2013;532:18-23
   PubMed Web of Science ®Google Scholar
• Swomley AM, Forster S, Keeney JT, et al. Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies. Biochim Biophys Acta 2014;1842:1248-57
   PubMed Web of Science ®Google Scholar
• Lenzen S. Oxidative stress: the vulnerable beta-cell. Biochem Soc Trans 2008;36:343-7
   PubMed Web of Science ®Google Scholar
• Lupi R, Del Guerra S, Mancarella R, et al. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab 2007;33:340-5
   PubMed Web of Science ®Google Scholar
• Basu A, Newman ED, Bryant AL, et al. Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J Nutr Metab 2013;2013:708381
   PubMedGoogle Scholar
• Li N, Stojanovski S, Maechler P. Mitochondrial hormesis in pancreatic beta cells: does uncoupling protein 2 play a role? Oxid Med Cell Longev 2012;2012:740849
   PubMed Web of Science ®Google Scholar
• Aquilano K, Baldelli S, Pagliei B, Ciriolo MR. Extranuclear localization of SIRT1 and PGC-1alpha: an insight into possible roles in diseases associated with mitochondrial dysfunction. Curr Mol Med 2013;13:140-54
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010;140:900-17
   PubMed Web of Science ®Google Scholar
• Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008;454:455-62
   PubMed Web of Science ®Google Scholar
• Garg AD, Kaczmarek A, Krysko O, et al. ER stress-induced inflammation: does it aid or impede disease progression? Trends Mol Med 2012;18:589-98
   PubMed Web of Science ®Google Scholar
• Cao SS, Kaufman RJ. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin Ther Targets 2013;17:437-48
   PubMed Web of Science ®Google Scholar
• Luoma PV. Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases. Ann Med 2013;45:194-202
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008;29:42-61
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Endoplasmic reticulum stress and atherosclerosis. Nat Med 2010;16:396-9
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Miani M, Cardozo AK. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 2013;56:234-41
   PubMed Web of Science ®Google Scholar
• Kim JY, Park KJ, Kim GH, et al. In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated beta-cell dysfunction during the progression of type-2 diabetes. Cell Signal 2013;25:2348-61
   PubMed Web of Science ®Google Scholar
• Tang X, Shen H, Chen J, et al. Activating transcription factor 6 protects insulin receptor from ER stress-stimulated desensitization via p42/44 ERK pathway. Acta Pharmacol Sin 2011;32:1138-47
   PubMed Web of Science ®Google Scholar
• Sabatini PV, Krentz NA, Zarrouki B, et al. Npas4 is a novel activity-regulated cytoprotective factor in pancreatic beta-cells. Diabetes 2013;62:2808-20
   PubMed Web of Science ®Google Scholar
• Gonzalez CD, Lee MS, Marchetti P, et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 2011;7:2-11
   PubMed Web of Science ®Google Scholar
• Hartley T, Brumell J, Volchuk A. Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic beta-cells. Am J Physiol Endocrinol Metab 2009;296:E1-10
   PubMed Web of Science ®Google Scholar
• Jung HS, Chung KW, Won Kim J, et al. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008;8:318-24
   PubMed Web of Science ®Google Scholar
• Masini M, Bugliani M, Lupi R, et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009;52:1083-6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Goldman S, Baerga R, et al. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc Natl Acad Sci USA 2009;106:19860-5
   PubMed Web of Science ®Google Scholar
• Goldman S, Zhang Y, Jin S. Autophagy and adipogenesis: implications in obesity and type II diabetes. Autophagy 2010;6:179-81
   PubMed Web of Science ®Google Scholar
• Kovsan J, Blüher M, Tarnovscki T, et al. Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 2011;96:E268-77
   PubMed Web of Science ®Google Scholar
• Wang Z, Oh E, Clapp DW, et al. Inhibition or ablation of p21-activated kinase (PAK1) disrupts glucose homeostatic mechanisms in vivo. J Biol Chem 2011;286:41359-67
   PubMed Web of Science ®Google Scholar
• Holmes RM, Yi Z, De Filippis E, et al. Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling. Diabetologia 2011;54(8):2122-31
   PubMed Web of Science ®Google Scholar
• Ghosh A, Mandal AK, Sarkar S, Das N. Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats. Drug Deliv 2011;18:451-9
   PubMed Web of Science ®Google Scholar
• Teodoro-Morrison T, Schuiki I, Zhang L, et al.78 overproduction in pancreatic beta cells protects against high-fat-diet-induced diabetes in mice. Diabetologia 2013;56:1057-67
   PubMed Web of Science ®Google Scholar
• Quan W, Lim YM, Lee MS. Role of autophagy in diabetes and endoplasmic reticulum stress of pancreatic beta-cells. Exp Mol Med 2012;44:81-8
   PubMed Web of Science ®Google Scholar
• Yao XG, Chen F, Li P, et al. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models. J Ethnopharmacol 2013;150:285-97
   PubMed Web of Science ®Google Scholar
• Hakonarson H, Grant SF. Genome-wide association studies (GWAS): impact on elucidating the aetiology of diabetes. Diabetes Metab Res Rev 2011;27:685-96
   PubMed Web of Science ®Google Scholar
• Goldfine AB, Kulkarni RN. Modulation of beta-cell function: a translational journey from the bench to the bedside. Diabetes Obes Metab 2012;14(Suppl 3):152-60
   PubMedGoogle Scholar
• Reddy AS, Zhang S. Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 2013;6:41-7
   PubMed Web of Science ®Google Scholar
• Viollet B, Guigas B, Sanz Garcia N, et al. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 2012;122:253-70
   PubMed Web of Science ®Google Scholar
• Koren-Gluzer M, Aviram M, Hayek T. Metformin inhibits macrophage cholesterol biosynthesis rate: possible role for metformin-induced oxidative stress. Biochem Biophys Res Commun 2013;439:396-400
   PubMed Web of Science ®Google Scholar
• Cao X, Li H, Tao H, et al. Metformin Inhibits Vascular Calcification in Female Rat Aortic Smooth Muscle Cells via the AMPK-eNOS-NO Pathway. Endocrinology 2013;154:3680-9
   PubMed Web of Science ®Google Scholar
• Xiong Y, Lu QJ, Zhao J, Wu GY. Metformin inhibits growth of hepatocellular carcinoma cells by inducing apoptosis via mitochondrion-mediated pathway. Asian Pac J Cancer Prev 2012;13:3275-9
   PubMed Web of Science ®Google Scholar
• Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian J Clin Biochem 2012;27:363-9
   Google Scholar
• Garber AJ. Attenuating cardiovascular risk factors in patients with type 2 diabetes. Am Fam Physician 2000;62:2633-42; 2645-2646
   PubMed Web of Science ®Google Scholar